Difference between revisions of "Part:BBa J23105"
KalenClifton (Talk | contribs) (→Baltimore Biocrew 2019 Characterization) |
Nickdelkis (Talk | contribs) (→Thessaly 2019 Characterization) |
||
Line 32: | Line 32: | ||
===Thessaly 2019 Characterization=== | ===Thessaly 2019 Characterization=== | ||
− | Thessaly 2019 sought to characterize the coding sequence of TEM-optimized beta-lactamase (BBa_I757010) under the regulation of the constituve Anderson Family promoters BBa_J23100, BBa_J23105, BBa_J23106, BBa_J23119. Beta-lactamase is an enzyme that hydrolyses beta-lactams (e.g. ampicillin) and is naturally found in | + | Thessaly 2019 sought to <b>characterize</b> the coding sequence of <b>TEM-optimized beta-lactamase</b> ([[Part:BBa_I757010]]) <b>under the regulation of the constituve Anderson Family promoters</b> [[Part:BBa_J23100]], [[Part:BBa_J23105]], [[Part:BBa_J23106]], [[Part:BBa_J23119]]. Beta-lactamase is an enzyme that hydrolyses beta-lactams (e.g. ampicillin) and is naturally found in prokaryotic cells. A colorimetric assay has been developed using nitrocefin as a substrate which after hydrolysis from beta-lactamase changes the reaction color, from yellow (380nm) to red (490nm). |
− | To achieve that, the coding sequence was assembled with each promoter, a universal RBS (BBa_B0034) and a double terminator(BBa_B0015). The parts were cloned in pSB1C3 and pSB1K3 and transformed into E. coli DH5a competent cells. For protein expression, the plasmids were transformed into E. coli BL21 (DE3) competent cells. | + | To achieve that, the coding sequence was assembled with each promoter, a <b>universal RBS</b> ([[Part:BBa_B0034]]) and a <b>double terminator</b>([[Part:BBa_B0015]]). The parts were cloned in pSB1C3 and pSB1K3 and transformed into <i>E. coli DH5a</i> competent cells. |
+ | |||
+ | In the photo below you can see the results of the primer addition using <b>overhang PCR</b>: | ||
+ | |||
+ | <html> | ||
+ | <head> | ||
+ | <title>HTML img Tag</title> | ||
+ | </head> | ||
+ | |||
+ | <body> | ||
+ | <img src="https://static.igem.org/mediawiki/parts/d/d7/T--Thessaly--gel_contribution.png" class= "center" width="800" | ||
+ | height="482"> | ||
+ | <p style="text-align: justify; font-size: 14px; font-family: MuliLight; color: black; margin-left: auto; margin-right: auto;"><b>Figure 1.</b> The results obtained after the PCR with the overhang primers for the different promoters of the Anderson family. We tested different annealing temperatures (45, 47 & 53℃) aiming for clear results. The expected band is at 1119bp and the ladder used was the 100bp DNA ladder by NEB.</p> | ||
+ | </body> | ||
+ | </html> | ||
+ | |||
+ | |||
+ | <p>For protein expression, the plasmids were transformed into <i>E. coli BL21 (DE3)</i> competent cells.</p> | ||
For the beta-lactamase assay, we set up the following experimental design: | For the beta-lactamase assay, we set up the following experimental design: | ||
− | 1. Grow BL21 (DE3) | + | 1. Grow BL21 (DE3) pre-culture overnight in 5ml LB (~16h) at a shaken incubator, 37 degrees C / 210rpm |
2. The following morning, measure the OD600 of overnight cultures | 2. The following morning, measure the OD600 of overnight cultures | ||
Line 51: | Line 68: | ||
6. Load 160 of culture in a 96-well plate (do triplicates). Add 40 ul 0.5 uM nitrocefin for a final concentration of 100nM | 6. Load 160 of culture in a 96-well plate (do triplicates). Add 40 ul 0.5 uM nitrocefin for a final concentration of 100nM | ||
− | 7. Measure the absorbance at 490nm (for nitrocefin hydrolysis) and 600nm (for cell growth) every 30 seconds for | + | 7. Measure the absorbance at 490nm (for nitrocefin hydrolysis) and 600nm (for cell growth) every 30 seconds for 2 hours in a microplate reader. Shake between readings. Because plateau was reached within the first 30 minutes of the reaction, only those are depicted in the graph. |
− | To ensure that the absorbance shown corresponds only to enzymatic activity by beta-lactamase, we included 3 controls in the experiment. | + | To ensure that the absorbance shown corresponds only to enzymatic activity by beta-lactamase, <b>we included 3 controls in the experiment</b>. |
− | The first control has M9 medium only (no cells) and nitrocefin, the second has empty BL21 (DE3) cells (no plasmid) and nitrocefin, while the third has BL21 (DE3) cells containing the plasmid but not the part (empty plasmid). | + | The first control has <b>M9 medium only</b> (no cells) and nitrocefin, the second has <b>empty BL21 (DE3) cells (no plasmid)</b> and nitrocefin, while the third has <b>BL21 (DE3) cells containing the plasmid but not the part (empty plasmid)</b>. |
To obtain comparable results, we normalized all values by dividing OD490 by OD600. | To obtain comparable results, we normalized all values by dividing OD490 by OD600. | ||
Line 66: | Line 83: | ||
<body> | <body> | ||
− | <img src="https://static.igem.org/mediawiki/parts/ | + | <img src="https://static.igem.org/mediawiki/parts/6/65/T--Thessaly--Graph-contrib.png" class= "center" width="800" |
− | height=" | + | height="508"> |
+ | <p style="text-align: justify; font-size: 14px; font-family: MuliLight; color: black; margin-left: auto; margin-right: auto;"><b>Figure 2.</b> The hydrolysis of nitrocefin enabled by the expression of the b-lactamase gene, under the control of different promoters (J23100, J23105, J23106 & J23119) of the Anderson family. The substrate (nitrocefin) hydrolysis (490nm) is divided by cell growth (600nm), in order to normalize all values.</p> | ||
</body> | </body> | ||
</html> | </html> | ||
+ | |||
+ | <p> The maximum expression of beta-lactamase was observed under control of the J23119 (brown line) which is the wild type promoter of the Anderson family. The expression is reduced with the J23100 and J23106 (yellow and purple line respectively), while the lowest expression levels were observed with the J23105 promoter (blue line). These results are in accordance with those from previous teams that measured fluorescence and the same pattern is observed. The controls conditions (pSB1C3 and BL21, or light purple and light blue respectively) confirm that the absorbance measured derives from beta-lactamase activity only, both quantitatively and visually.</p> | ||
+ | |||
+ | Below you can see the 96-well plate of the assay: | ||
+ | |||
+ | <html> | ||
+ | <head> | ||
+ | <title>HTML img Tag</title> | ||
+ | </head> | ||
+ | |||
+ | <body> | ||
+ | <img src="https://static.igem.org/mediawiki/parts/7/7b/T--Thessaly--plate_reader_contribution.png" class= "center" width="800" | ||
+ | height="467"> | ||
+ | <p style="text-align: justify; font-size: 14px; font-family: MuliLight; color: black; margin-left: auto; margin-right: auto;"><b>Figure 3.</b>The observed color change due to the hydrolyzation of nitrocefin due to the production of b-lactamase, after a 2-hour enzymatic assay.</p> | ||
+ | </body> | ||
+ | </html> | ||
+ | |||
+ | <p><b>Note that the picture was taken after the plate-reader assay was completed and all conditions had reached a plateau, except the controls.</b></p> | ||
===Baltimore Biocrew 2019 Characterization=== | ===Baltimore Biocrew 2019 Characterization=== |
Revision as of 16:19, 20 October 2019
constitutive promoter family member
Variant RFP (au) J23112 1 J23103 17 J23113 21 J23109 106 J23117 162 J23114 256 J23115 387 J23116 396 J23105 623 J23110 844 J23107 908 J23106 1185 J23108 1303 J23118 1429 J23111 1487 J23101 1791 J23104 1831 J23102 2179 J23100 2547 |
Constitutive promoter family
Parts J23100 through J23119 are a family of constitutive promoter parts isolated from a small combinatorial library. J23119 is the "consensus" promoter sequence and the strongest member of the family. All parts except J23119 are present in plasmid J61002. Part J23119 is present in pSB1A2. This places the RFP downstream of the promoter. Reported activities of the promoters are given as the relative fluorescence of these plasmids in strain TG1 grown in LB media to saturation. See part BBa_J61002 for details on their use.
These promoter parts can be used to tune the expression level of constitutively expressed parts. The NheI and AvrII restriction sites present within these promoter parts make them a scaffold for further modification. JCAraw
Manchester 2017 used this part to create part LowPromoter_PduD(1-20)_mCherry (BBa_K2213006). This promoter was combined with PduD(1-20) to create a tag with lower expression levels. The mCherry tagged PduD(1-20) localisation tag displayed lower fluorescence levels under the low promoter as compared to under medium (BBa_K2213007) and high strength (BBa_K2213008) promoters, demonstrating correct function.
More information can be found here: https://parts.igem.org/Part:BBa_K2213006
GreatBay_China 2018:
Team GreatBay_China 2018 characterized J23119, Part:BBa_J23105, and Part:BBa_J23101 by assembling them with Part:BBa_B0034 and a sfGFPPart:BBa_I746916 on three vectors: pUC20 (copy number about 500/cell), pR6K (copy number about 15/cell), pSC101 (copy number about 2/cell). Then we measured the fluorescence by Flow Cytometry as a reference for the TALE stabilized promoter library.
The result indicate that the strength of J23119, J23105, and J23101 are about the same as described by team iGEM2006_Berkeley, and the fluorescence increases as the copy number of the vector increases
Thessaly 2019 Characterization
Thessaly 2019 sought to characterize the coding sequence of TEM-optimized beta-lactamase (Part:BBa_I757010) under the regulation of the constituve Anderson Family promoters Part:BBa_J23100, Part:BBa_J23105, Part:BBa_J23106, Part:BBa_J23119. Beta-lactamase is an enzyme that hydrolyses beta-lactams (e.g. ampicillin) and is naturally found in prokaryotic cells. A colorimetric assay has been developed using nitrocefin as a substrate which after hydrolysis from beta-lactamase changes the reaction color, from yellow (380nm) to red (490nm).
To achieve that, the coding sequence was assembled with each promoter, a universal RBS (Part:BBa_B0034) and a double terminator(Part:BBa_B0015). The parts were cloned in pSB1C3 and pSB1K3 and transformed into E. coli DH5a competent cells.
In the photo below you can see the results of the primer addition using overhang PCR:
Figure 1. The results obtained after the PCR with the overhang primers for the different promoters of the Anderson family. We tested different annealing temperatures (45, 47 & 53℃) aiming for clear results. The expected band is at 1119bp and the ladder used was the 100bp DNA ladder by NEB.
For protein expression, the plasmids were transformed into E. coli BL21 (DE3) competent cells.
For the beta-lactamase assay, we set up the following experimental design:
1. Grow BL21 (DE3) pre-culture overnight in 5ml LB (~16h) at a shaken incubator, 37 degrees C / 210rpm
2. The following morning, measure the OD600 of overnight cultures
3. Dilute all cultures to OD600¬ = 0.05 in M9 minimal medium
4. Grow cells 37 degrees C /210 RPM until OD600=0.4-0.6 (~2h)
5. Dilute all cells to the same OD600 (e.g. 0.4)
6. Load 160 of culture in a 96-well plate (do triplicates). Add 40 ul 0.5 uM nitrocefin for a final concentration of 100nM
7. Measure the absorbance at 490nm (for nitrocefin hydrolysis) and 600nm (for cell growth) every 30 seconds for 2 hours in a microplate reader. Shake between readings. Because plateau was reached within the first 30 minutes of the reaction, only those are depicted in the graph.
To ensure that the absorbance shown corresponds only to enzymatic activity by beta-lactamase, we included 3 controls in the experiment. The first control has M9 medium only (no cells) and nitrocefin, the second has empty BL21 (DE3) cells (no plasmid) and nitrocefin, while the third has BL21 (DE3) cells containing the plasmid but not the part (empty plasmid). To obtain comparable results, we normalized all values by dividing OD490 by OD600.
The results are shown in the graph below
Figure 2. The hydrolysis of nitrocefin enabled by the expression of the b-lactamase gene, under the control of different promoters (J23100, J23105, J23106 & J23119) of the Anderson family. The substrate (nitrocefin) hydrolysis (490nm) is divided by cell growth (600nm), in order to normalize all values.
The maximum expression of beta-lactamase was observed under control of the J23119 (brown line) which is the wild type promoter of the Anderson family. The expression is reduced with the J23100 and J23106 (yellow and purple line respectively), while the lowest expression levels were observed with the J23105 promoter (blue line). These results are in accordance with those from previous teams that measured fluorescence and the same pattern is observed. The controls conditions (pSB1C3 and BL21, or light purple and light blue respectively) confirm that the absorbance measured derives from beta-lactamase activity only, both quantitatively and visually.
Below you can see the 96-well plate of the assay:
Figure 3.The observed color change due to the hydrolyzation of nitrocefin due to the production of b-lactamase, after a 2-hour enzymatic assay.
Note that the picture was taken after the plate-reader assay was completed and all conditions had reached a plateau, except the controls.
Baltimore Biocrew 2019 Characterization
Goal
We, the Baltimore Biocrew, decided to characterize some of the Anderson promoters. These promoters are highly used by iGEM but the relative expression of these promoters have been routinely determined by measuring the fluorescence of a reporter protein. However, the function of a promoter is to start transcription of a gene so it may be more informative to measure the amount of RNA (instead of protein) produced by a reporter gene. Therefore, we decided to further characterize a selection of the Anderson promoters (J23100, J23101, J23103, J23105, J23118) by measuring RNA using Quantitative Polymerase Chain Reaction (qPCR).
Results
We did data analysis using the Livak Method (a standard, comparative method) to determine the relative strength of the promoters from the qPCR data using rrSD as our reference gene, RFP as our target gene, and J23100 as our calibrator sample.
Example:
ΔCT(J23101) = CT(RFP, J23101) – CT(rrSD, J23101)
ΔΔCT(J23101) = ΔCT(J23101) – ΔCT(J23100)
2^(–ΔΔCT) = relative expression ratio
In our first trial of qPCR (8/03/19), we were able to measure the relative strengths for J23100, J23101, J23103, and J23105 which were 1.00, 0.00, 0.81, and 1.93, respectively. Since these strengths did not match the relative expression levels reported by iGEM2006_Berkeley, we repeated the qPCR (8/10/19) with the same cDNA. The strengths from this second trial were 1.00, 0.00, 0.37, and 0.20. We repeated it again and the relative strengths that we got on 10/12/19 for J23100, J23101, J23103, and J23103 were 1, 0, 2.91, and .32. Next, we made new cDNA by growing new liquid cultures, extracting RNA again, and repeating reverse transcription. From the new cDNA, we repeated the qPCR procedure two more times. The relative strengths for that we got on 9/28/19 for J23100, J23101, J23103, J23105, and J23118 were 1, 24.63, .36, 1.76, and .25. The relative strengths that we got on 10/12/19 for J23100, J23101, J23103, and J23105 were 1, 45.97, 3.20, and 1.26. In addition we measured promoter J23118 twice and got the strengths 1.13 and 1.32.
Here is the relative promoter strengths that we got from the qPCR. Baltimore BioCrew in blue compared to the 2006 Berkeley iGEM in orange.
To support our RNA measurements we also measured fluorescence of the liquid cultures we used to extract RNA. The cultures were grown overnight so we expected the bacteria to be at the stationary phase, but we measured OD to normalize any differences in growth.
Promoter | OD | fluorescence | fluorescence divided by OD | corrected relative expression | reported relative expression |
---|---|---|---|---|---|
BBa_J23100 | 0.876 | 250 | 285.38 | 1 | 1 |
BBa_J23101 | 0.674 | 255 | 378.33 | 1.33 | 0.7 |
BBa_J23103 | 1.1 | 230 | 209.09 | 0.73 | 0.01 |
BBa_J23105 | 1.08 | 215.74 | 209.09 | 0.76 | 0.24 |
BBa_J23118 | 1.04 | 238 | 228.84 | 0.80 | 0.56 |
After redoing our protocol many times and trying to compare our results to 2006 Berkeley iGEM team we concluded that our data doesn’t quite match theirs. The different results in strengths could be caused by many different factors while doing our protocols. However, we have succeeded in characterizing the different strength Andersons promoters (J23100, J23101, J23103, J23105, J23118) by measuring RNA using Quantitative Polymerase Chain Reaction (qPCR). In conclusion, we successfully reached our goal in bringing new data to the characterizations of 5 different Andersons Promoters. In the future, it would be good for other iGEM teams to try to measure RNA as well so there will be a standard qPCR protocol for iGEM.